510(k) K955100
K955100 is an FDA 510(k) premarket notification submitted by Diagnostic Reagents, Inc. for the device "CARBAMAZEPINE EIA TEST". The FDA issued a decision of Substantially Equivalent on Dec 13, 1995. The device falls under product code KLT (Enzyme Immunoassay, Carbamazepine), a Class II device regulated under 21 CFR 862.3645. Diagnostic Reagents, Inc. has 65 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Dec 13, 1995
- Date Received
- Nov 8, 1995
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Enzyme Immunoassay, Carbamazepine
- Device Class
- Class II
- Regulation Number
- 862.3645
- Review Panel
- TX
- Submission Type
- 510(k)
Need the full FDA record for Diagnostic Reagents, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.